The ␤ adrenergic system plays a key role in regulating energy balance through the stimulation of both thermogenesis and lipid mobilization in brown and white adipose tissues in human and various animal models. Recent studies have suggested that a missense Trp64Arg mutation in the ␤ 3 adrenergic receptor (ADRB3) gene was involved in obesity and insulin resistance. We have investigated the effect of this mutation on obesity-related phenotypes in two cohorts: the Québec Family Study (QFS) and the Swedish Obese Subjects (SOS). In QFS, no association was found between this mutation and body mass index (BMI), body fat including abdominal visceral fat, resting metabolic rate, various diabetes and cardiovascular risk factors, and changes in body weight and body fat over a 12-yr period. With the exception of RMR ( P ϭ 0.04), no evidence of linkage was detected between the mutation and phenotypes of QFS based on sib-pair data. In SOS, the frequency of the Trp64Arg allele was not significantly different between nonobese and obese female subjects and no association was found between the mutation and body weight gain over time. These findings do not support the view that there is an association between the Trp64Arg mutation in the ADRB3 gene and obesity. ( J. Clin. Invest. 1996. 98:2086-2093.)
Introduction
There is strong evidence suggesting that human obesity has both genetic and environmental determinants (1) . It is also established that an obese state results from an imbalance between caloric intake and energy expenditure, and that a low resting metabolic rate could be predictive of weight gain (2) . In this regard, the adrenergic system plays a key role in regulating energy balance through the stimulation of both thermogenesis and lipid mobilization in brown and white adipose tissues in humans and various animal models (3, 4) . Although these effects have been mainly attributed to ␤ 1 and ␤ 2 adrenergic receptors, the relative contribution in catecholamine action of a third ␤ adrenoceptor subtype, which has been cloned in man (5-7), bovines (8) , and rodents (9) (10) (11) should also be considered (3, 4) .
Numerous pharmacological studies performed with highly selective ␤ 3 adrenergic agonists considered as potent antiobesity and antidiabetic drugs (4) have confirmed the involvement of ␤ 3 adrenoceptors in both adipocyte lipolysis and thermogenic activity in various laboratory animals (3, 12) . In contrast, although ␤ 3 adrenergic receptors were clearly expressed in a variety of human fat depots (13) , their physiological importance in man remains controversial (14) . In vitro studies have revealed little or no lipolytic response to ␤ 3 adrenoceptor agents in either isolated subcutaneous fat cells (15-17) or adipose tissue fragments (18) . However, the existence of functional ␤ 3 adrenoceptors assessed by in vitro assays has already been demonstrated in omental adipocytes (19, 20) whereas the lack or the presence of only a weak proportion of this adrenoceptor subtype in intraabdominal fat cells has been reported by others (21, 22) . On the other hand, in vivo studies using the microdialysis technique have revealed a weaker role of ␤ 3, compared to ␤ 1, and ␤ 2 adrenergic receptors, in the control of both lipolysis and nutritive blood flow in human subcutaneous adipose tissue (23, 24) . Despite these conflicting results which seem to be mainly due to the selectivity of the ␤ 3 adrenergic compounds tested and the methodology used, an increased ␤ 3 adrenoceptor component in visceral adipose tissue could be responsible for the enhanced delivery of free fatty acids into the portal vein, a phenomenon which may contribute to the development of the metabolic disturbances generally observed in abdominal obesity (20, 25) . An abnormality in the ␤ 3 adrenergic receptor (ADRB3) 1 could therefore potentially represent a link between abdominal obesity and insulin resistance.
A missense mutation in codon 64 of the ADRB3 gene that results in the replacement of tryptophan by arginine in the first intracellular loop of the receptor protein, has recently been reported in various ethnic groups including Pima Indians, known for their high prevalence of obesity and noninsulin dependent diabetes mellitus (NIDDM) (26) , Finns (27) , French Caucasians (28) and Japanese (29). In addition, the Tryptophan 64 arginine (Trp64Arg) mutation has been associated with an early onset of NIDDM (26) and an increased weight gain with age in morbidly obese patients (28) . A defect in the ␤ 3 adren-ergic receptor could be of clinical importance in the pathophysiology of obesity because it could lead to alterations in signal transduction and regulatory mechanisms and result in decreased adipose tissue lipolysis and resting metabolic rate as well as an exaggerated body fat accretion. It has recently been suggested that the Trp64Arg allele of the ADRB3 gene could be predictive of some difficulties in losing weight in obese Japanese women (30). Therefore, the aims of the present study were: ( a ) to investigate the prevalence of the Trp64Arg ␤ 3 adrenergic receptor mutation in two different cohorts: the Québec Family Study (QFS), and the Swedish Obese Subjects (SOS); and ( b ) to investigate the relationships between the Trp64Arg mutation in the ADRB3 receptor gene and obesity-related phenotypes using these data bases.
Methods

Description of the cohorts
The first cohort was that of the QFS (31) . It consists of 1,628 individuals from French-Canadian families living in and around Québec City and recruited through the media during the years 1978-1981 (Phase 1). Each subject was examined by a physician in order to exclude individuals with metabolic disorders such as diabetes and dyslipidemias. The subjects gave their written consent to participate in the study which received the approval of the Laval University Medical Ethics Committee. Between 1989 and 1993 (Phase 2), a subset of these QFS families was remeasured and permanent lymphoblastoid cell lines were established for each individual and used to extract DNA.
From Phase 2 of QFS, we studied 552 subjects, 18 yr of age and older, from 126 nuclear families. DNA was available from 242 biologically unrelated adults from the parental generation (119 men whose age ranged between 40 and 73 yr, and 123 women who were from 36 to 68 yr). Sib-pair linkage analyses were also performed and the number of pairs ranged from 142 to 255 depending on the phenotype considered. The phenotypic characteristics of the unrelated adults are shown in Table I . Changes in body mass and body fat phenotypes over a 12-yr period are presented in Table II .
The second sample comes from the SOS (32, 33). Data presented in this paper are based on a subsample on 385 female obese subjects (37-60-yr-old) from SOS, whose body mass index (BMI) was greater than 33 kg/m 2 , examined in both urban and rural counties in Sweden. A description of the physical characteristics of this cohort sample is given in Table III . An age-matched (48.4 vs. 47.8 yr) nonobese subset of 83 Swedish women, with a BMI less than 27 kg/m 2 , served as a control group. DNA was extracted from total blood for these subjects.
Obesity-related phenotypes QFS Cohort. BMI was calculated as body weight (kg) divided by squared height (m 2 ). Maximal weight over the last 10 yr was assessed by means of a questionnaire. Body density was determined by the hy- (34) and pulmonary residual volume was measured using the helium dilution method (35) . Percent body fat was derived from body density using the Siri equation (36) . Fat mass was determined by multiplying percent body fat by body weight. Waist circumference was measured at the smallest circumference above the level of the iliac crest. Skinfolds were measured on the left side of the body using a Harpenden skinfold caliper and following the procedures recommended at the Airlie Conference (37) . The sum of six skinfolds measurements (biceps, triceps, medial calf, subscapular, suprailiac, and abdominal) was considered as an indicator of total subcutaneous fat. As body fat measurements were obtained in 1978-1981 and in 1989-1993, changes over the 12-yr period were also considered. Total abdominal and visceral fat areas were obtained only during Phase 2 (1989-1993) using computerized tomography which was performed on a scanner (model Somatom DRH; Siemens, Erlangen, Germany) as previously described (38) . The measurement of resting metabolic rate (RMR) was performed in Phase 2 as previously described (39). RMR was assessed in the morning after a 12-h fast by indirect calorimetry with a ventilated hood. The Weir formula was used to calculate energy expenditure and values were expressed in kcal/ min (40). Several phenotypes pertaining to cardiovascular and diabetes risk factors are also considered in this paper. Resting blood pressure was measured in the morning, after the RMR assessment, on subjects who were in a fasted state and free of caffeine and tobacco products. A 75-g oral glucose tolerance test (OGTT) was performed in the morning after a 12-h fast. Blood samples were collected at 15-min intervals during the first hour following the glucose ingestion and every 30 min for the subsequent 2 h as previously described (41) . Plasma glucose was enzymatically measured (42), whereas plasma insulin was measured by radioimmunoassay with polyethylene glycol separation (43) . Glucose and insulin total areas under the curve during the OGTT were determined by the trapezoid method.
SOS cohort. BMI was available on the SOS and control female subjects. Before undergoing a health examination, all subjects completed a series of questionnaires on current and past health status, including various aspects of weight history such as information on recalled weights at ages 20, 30, 40, 45, 50, 55 as appropriate, recent weight changes in the previous 6, 12, and 24 mo, and the age at which obesity became "a problem" (33) .
Genetic analyses
Genomic DNA was isolated from either whole blood samples (SOS cohort) or from permanent lymphoblastoid cell lines (44; QFS cohort), by proteinase K and the phenol/chloroform extraction procedure followed by dialysis. The T to C transversion at codon 64 generates a new MspI restriction site. Specific primers were defined to cover this MspI restriction site (Figs. 1 A and B) . Each 30 l reaction contained 100 ng of genomic DNA, 250 ng of each primer, 1.5 mM MgCl 2 , 50 mM KCl, 10 mM Tris/HCl pH 8.3, 0.001% gelatin, 200 M dNTPs, 1.5 unit Taq polymerase, and 10% DMSO. The reactions were incubated at 95ЊC for 3 min, 60ЊC for 15 s, 72ЊC for 30 s followed by 29 cycles at 95ЊC for 15 s, 60ЊC for 15 s, and 72ЊC for 30 s using a thermal cycler (model 9600; Perkin-Elmer Cetus Instruments, Branchburg, NJ). PCR reactions were directly digested by adding 15 U of MspI enzyme (BRL) for 18 h at 37ЊC and the fragments obtained were separated on a 8% acrylamide gel and visualized under UV light after staining with ethidium bromide. Two normal homozygotes (99/99) and the only mutant homozygote (70/70) were subjected to direct dideoxy sequence analysis of the PCR products on both strands with an Amplicycle sequencing kit (Perkin-Elmer) to confirm the T to C change at nucleotide 189 of the ADRB3 gene (Fig. 1 C) .
Statistical analyses
Analyses were performed with the Statistical Software Package (SAS, Cary, NC). In the QFS cohort, body weight, BMI, waist circumference, maximal weight over the past 10 yr, percent body fat, fat mass, fat free mass, sum of six skinfolds, and blood pressure were adjusted for age in each gender subsample. Abdominal fat areas were also adjusted for total fat mass, in addition to age. RMR was adjusted for age, fat mass, and fat free mass. A Student t test was used to test for the difference in a quantitative phenotype between the carriers and noncarriers of the ADRB3 Trp64Arg mutation in biologically unrelated males and females from the parental generation. Comparisons of genotypes and allelic frequencies in both QFS and SOS cohorts were performed using chi-square tests.
The sib-pair linkage procedure (45, 46) was used to investigate the presence of linkage between the quantitative phenotypes and the Trp64Arg mutation at the ADRB3 locus. Briefly, in the presence of linkage between the marker locus and a putative gene influencing the phenotype, sibs sharing a greater proportion of alleles identical by descent at the marker locus will be more similar for the phenotype of interest. The squared sib-pair phenotypic difference is regressed on the expected proportion of marker alleles identical by descent at the locus. A one-sided t test is then used to test whether the regression coefficient is different from 0. A significant negative relationship between the squared sib-pair phenotypic difference and the marker locus is taken as evidence of linkage between the marker locus and the phenotype. The major advantage of this method is that it is nonparametric and requires no assumption about the genetic model underlying the expression of the phenotype studied. The linkage analysis was performed using the SIBPAL software program of the SAGE Statistical Package (47).
In the SOS cohort, the age and weight history variables were compared between carriers and noncarriers of the Trp64Arg mutation of the ADRB3 gene, using t tests. Differences in current weight or maximal weight versus weight at 20 yr of age were adjusted for the length of follow-up. Regression lines of weight gain over time were compared between genotypes for both the intercept and the slope. Using quintiles, analyses were also undertaken with the low and high weight gainers (first and last quintile). As subjects available for these analyses vary, the actual number of subjects for each variable is indicated in the Tables. Statistical significance was judged at P Յ 0.05.
Results
The nucleotide sequence of the human ADRB3 gene retrieved from GenBank (48) was used to select a fragment of 153 bp spanning codon 22 to codon 72 within which a mutation at codon 64 has been reported (26) . A 1.5-kb DNA fragment amplified by PCR and covering entirely the first exon of the ADRB3 gene did not reveal any polymorphism tested with a battery of 20 restriction enzymes (not shown). A first screen of nine lean and nine obese subjects with MspI digestion yielded two individuals displaying an additional 70 bp fragment in contrast to the common 99-and 54-bp bands (Fig. 1 A) . Figs. 1 B and C present the nucleotide sequence of the amplified 153-bp PCR fragments from two homozygotes for each of the alleles which confirm the T to C substitution at nucleotide 189 creating the MspI restriction site. Fig. 2 illustrates the pedigree of two lean adult probands from the QFS cohort with the Trp64Arg mutation. In family 31, the mother does not carry the Trp64Arg mutation and the father is heterozygous whereas all the offspring carry the Trp64Arg mutation. In family 225, the father does not carry the mutation and the mother is heterozygous. Three of four offspring as well as monozygotic twins carry the Trp64Arg mutation. This clearly demonstrates the Mendelian inheritance of this mutation. Interestingly, none of the subjects in these two families were classified as obese, as all BMIs were lower than 26 kg/m 2 . In the QFS cohort, allelic frequencies for the carriers and noncarriers of the Trp64Arg mutation of ADRB3 were 0.92 and 0.08, respectively. The three genotypes (normal homozygous, mutant heterozygous, and mutant homozygous) were observed (Table IV) . In the SOS cohort, similar relative allelic frequencies were observed. However, there was no difference in the allelic frequencies of control versus SOS female obese subjects (Table IV) . Genotype frequencies were all in HardyWeinberg equilibrium.
Association studies. When unrelated subjects from the parental generation of the QFS cohort were studied, no difference was found in the genotype distribution between genders. Moreover, as no significant genotype-gender interaction was observed for the different phenotypic variables tested (not shown), analyses were performed on both men and women pooled together. Cross-sectional analyses using data from QFS Phase 2 did not reveal any difference in the various anthropometric and regional fat distribution indicators (including total, visceral, and subcutaneous abdominal fat areas) as well as in RMR, between carriers vs. noncarriers of the Trp64Arg mutation (Table V) . In addition, carriers and noncarriers of the Trp64Arg mutation displayed similar glucose, insulin, and resting blood pressure values (Table VI) . In addition, the absolute changes in body weight, BMI, subcutaneous fat, percent body fat, fat mass and fat free mass over the 12-yr period were not different between both genotypes (Table VII) .
In the SOS cohort of obese women, the current age, BMI, waist circumference, and age of onset of weight problem were similar among carriers and noncarriers of the Trp64Arg mutation. There was no difference for indicators of weight history and for the weight gain, i.e., current weight minus weight at 20-yr-old, even after adjustment for difference in the duration of the follow-up period (Table VIII) . During the periods 20-30, MeanϮSD. Associations with Trp64Arg mutation were assessed using t tests. Body weight, BMI, percent body fat, fat mass, fat free mass, and subcutaneous fat were adjusted for age. Abdominal total, visceral, and subcutaneous fat areas were adjusted for age and fat mass. Resting metabolic rate (RMR) was adjusted for age, fat mass, and fat free mass. MeanϮSD. Associations with Trp64Arg mutation were assessed using t tests. Fasting plasma glucose and insulin levels, glucose and insulin areas, and systolic and diastolic blood pressures were all adjusted for age.
30-40, 40-50, and 50-55 yr, the average rate of reported weight gain (about 1 kg/yr) was similar in the SOS subjects and controls. The intercept and the slope of the regression line were also similar in the two groups as shown in Fig. 3 . Moreover, after division of the cohort in quintiles of current weight minus weight at 20 yr, there was no significant difference in the frequency of the Trp64Arg mutation between the five groups (chi-square ϭ 8.00, P ϭ 0.43) or between the high (60Ϯ8 kg) and low weight gainers (18Ϯ10 kg) (Fig. 4) .
Linkage study. Results from the sib-pair linkage analysis in the QFS are shown in Table IX . No significant linkage was found for the various anthropometric and fat distribution phenotypes (P values ranging from 0.21 to 0.81). A possible exception was a weak linkage (P ϭ 0.04) with resting metabolic rate.
Discussion
We have described a MspI restriction site in the human ␤3 adrenergic receptor gene. This particular point mutation was first documented in Pima Indians (26) and recently fully described in other populations (26) (27) (28) (29) . It has already been demonstrated that the Trp64Arg mutation abolished a recognition site for the endonuclease BstN1 (CC/WGG) (26) (27) (28) (29) . As the Trp64Arg mutation creates a new MspI site (C/CGG), the RFLP detection is straightforward. The Trp64Arg mutation has been studied in many populations such as Pima Indians, and Mexican, black, and white Americans (26), normal nondiabetic and diabetic Finnish subjects (27) , French morbidly obese people (28) , as well as Japanese subjects (29). In the present study, we document the allelic frequencies for two other Caucasian populations: 56French Canadians and Swedes. It should be noted that the allelic frequency of the Trp64Arg mutation among these populations is quite variable as it ranges from 0.04 and 0.08 in the SOS and QFS cohorts to 0.37 in Japanese subjects.
The present results are in accordance with data from other studies in which no difference has been found in the allelic frequencies between obese and nonobese subjects (26, 28, 30) . Only one study performed on obese and nonobese Japanese subjects (29) has reported a significant difference in allelic frequencies between the two groups. This mutation has also been reported to be more frequent in Japanese than in other ethnic MeanϮSD. Associations with Trp64Arg mutation were assessed using t tests. Changes in body weight, body mass index, subcutaneous fat, percent body fat, fat free mass, and fat mass were adjusted for age at the beginning of the follow-up period. (26) (27) (28) (29) (30) is that the Trp64Arg allele may play a role in predisposing patients to abdominal obesity, which may in turn lead to insulin resistance and an earlier onset of NIDDM. In addition, a low resting metabolic rate could lead to an accumulation of energy stores, weight gain, and therefore an obese state. Based upon both association and linkage analyses, the present study did not reveal any significant difference between carriers and noncarriers for the Trp64Arg mutation for various obesity-related phenotypes in contrast to what has been previously reported by others (26) (27) (28) . Moreover, the fact that abdominal visceral fat level is similar among Trp64Arg carriers and noncarriers does not support the hypothesis that this ADRB3 mutation leads to an excessive abdominal fat deposition, as already proposed by others (27) . These results are concordant with those of a recent study performed on normal weight and obese nondiabetic subjects which revealed a lack of significant difference in anthropometric and metabolic variables as well as in visceral fat cell size and lipolytic response to noradrenaline or to the selective ␤3 agonist CGP12177 between heterozygotes and homozygotes for the Trp64Arg mutation (49) . The present study emphasizes the fact that this ADRB3 receptor mutation does not influence body fat and abdominal visceral fat levels. However, a recent knock-out gene study has shown that ␤3 adrenoceptor deficient mice have moderately increased fat stores, suggesting that a total lack of ADRB3 activity may influence energy balance (50).
The base change predicts a replacement of tryptophan by arginine at position 64 (Trp64Arg), an amino acid located in the first of the three intracellular loops of the ␤3 adrenoceptor (26, 51) which is thought to be important for the proper movement of the receptor to the adipose cell surface and also probably for its coupling to Gs proteins. However, species such as bovine, rat, and mouse have arginine instead of tryptophan at the same position of the ␤3 adrenergic receptor (52) . A computer-aided molecular modeling of the complex formed by the ADRB3 receptor and Gs proteins has shown that residues 134, 227 → 234, 276 → 289, 347, and 361 of the ␤3 adrenoceptor could be involved in the formation of this complex (53). Based on this simulation, the ␣-helix structure of the first intracellular loop (Ala 61-Leu 68) does not appear to be critical. In this regard, deletion and substitution mutagenesis experiments performed on the ␤2 adrenoceptor have highlighted that the third intracellular loop (i3) is the main domain involved in both ligand binding interactions and coupling of the receptor to Gs proteins (54) . Similarly, it has recently been reviewed that amino acids residues responsible for the interaction between ␤3 adrenoceptors and Gs proteins are located near the intracellular loop i3 and the C-terminal region, whereas the first intracellular loop of these receptors does not appear as an important determinant of the physiological responsiveness (55) .
In summary, data obtained from two different cohorts, the QFS and the SOS, did not reveal any association between obesity-related phenotypes and the ADRB3 Trp64Arg mutation. The results suggest that the Trp64Arg mutation of the ADRB3 gene is unlikely to play a significant role in obesity, the accumulation of body fat over time, or abdominal visceral fat level. 
